Glutathione and pH serial responsive functional mesoporous silica nanoparticles for drug delivery

被引:1
|
作者
He, Liang [1 ,2 ]
Nan, Xueyan [1 ]
Wang, Tong [1 ]
Bai, Pengli [1 ,3 ,4 ]
机构
[1] Chinese Acad Sci, Suzhou Inst Biomed Engn & Technol, Suzhou 215163, Peoples R China
[2] Qingdao Univ, Coll Chem & Chem Engn, Inst Biomed Mat & Engn, Qingdao 266071, Peoples R China
[3] Univ Sci & Technol China, Hefei 230026, Peoples R China
[4] Tianjin Guokeyigong Sci & Technol Dev Co Ltd, Tianjin 300399, Peoples R China
关键词
CHITOSAN NANOPARTICLES; GRAPHENE OXIDE; CARBON DOTS; CO-DELIVERY; CANCER; NANOCARRIERS; DOXORUBICIN; THERAPY;
D O I
10.1049/mnl.2019.0317
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
In this work, a novel glutathione and pH serial dual-responsive drug delivery system has been developed, which was constructed with chitosan (CS), carbon dots (CDs) and hyaluronic acid (HA) modified the mesoporous silica nanoparticles (MSNs). The system showed excellent drug loading efficiency, controlled release and targeted delivery. In addition, the platform (MSN-CS@HA-CDs) exhibited fluorescence imaging property. The prepared drug delivery system appeared to be a promising cancer treatment platform.
引用
收藏
页码:291 / 295
页数:5
相关论文
共 50 条
  • [1] Redox and pH double stimulus-responsive mesoporous silica nanoparticles for drug delivery
    Chen, Yang
    Wang, Yi-Fan
    He, Liang
    Wang, Zhe
    Shen, You-Qing
    Cong, Hai-Lin
    Yu, Bing
    FERROELECTRICS, 2019, 549 (01) : 1 - 11
  • [2] Biphenyl Wrinkled Mesoporous Silica Nanoparticles for pH-Responsive Doxorubicin Drug Delivery
    Lin, Jason
    Peng, Chuanqi
    Ravi, Sanjana
    Siddiki, A. K. M. Nur Alam
    Zheng, Jie
    Balkus, Kenneth J., Jr.
    MATERIALS, 2020, 13 (08)
  • [3] pH-Responsive Drug Delivery and Imaging Study of Hybrid Mesoporous Silica Nanoparticles
    Li, Zhongtao
    Guo, Jing
    Qi, Guiqiang
    Zhang, Meng
    Hao, Liguo
    MOLECULES, 2022, 27 (19):
  • [4] Application of mesoporous silica nanoparticles as drug delivery carriers for chemotherapeutic agents
    Alyassin, Yasmine
    Sayed, Elshaimaa G.
    Mehta, Prina
    Ruparelia, Ketan
    Arshad, Muhammad S.
    Rasekh, Manoochehr
    Shepherd, Jennifer
    Kucuk, Israfil
    Wilson, Philippe B.
    Singh, Neenu
    Chang, Ming-Wei
    Fatouros, Dimitrios G.
    Ahmad, Zeeshan
    DRUG DISCOVERY TODAY, 2020, 25 (08) : 1513 - 1520
  • [5] Preparation of pH-Responsive Mesoporous Silica Nanoparticles and Their Application in Controlled Drug Delivery
    Yuan, Li
    Tang, Qianqian
    Yang, Dong
    Zhang, Jin Zhong
    Zhang, Fayong
    Hu, Jianhua
    JOURNAL OF PHYSICAL CHEMISTRY C, 2011, 115 (20) : 9926 - 9932
  • [6] Multifunctional polymer-capped mesoporous silica nanoparticles for pH-responsive targeted drug delivery
    Niedermayer, Stefan
    Weiss, Veronika
    Herrmann, Annika
    Schmidt, Alexandra
    Datz, Stefan
    Mueller, Katharina
    Wagner, Ernst
    Bein, Thomas
    Braeuchle, Christoph
    NANOSCALE, 2015, 7 (17) : 7953 - 7964
  • [7] Dendrimerlike Mesoporous Silica Nanoparticles as pH-Responsive Nanocontainers for Targeted Drug Delivery and Bioimaging
    Dai, Liangliang
    Zhang, Qingfeng
    Li, Jinghua
    Shen, Xinkun
    Mu, Caiyun
    Cai, Kaiyong
    ACS APPLIED MATERIALS & INTERFACES, 2015, 7 (13) : 7357 - 7372
  • [8] pH and temperature dual-responsive hollow mesoporous silica nanoparticles for drug encapsulation and delivery
    Wu, Shu
    Wang, Chen
    Chen, Xia
    Bai, Lu
    Wu, Qiuhua
    Zhang, Guolin
    JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY, 2024,
  • [9] Magnetic targeting and pH-microwave dual responsive Janus mesoporous silica nanoparticles for drug encapsulation and delivery
    He, Yuhai
    Wang, Chen
    Wu, Qiuhua
    Zhang, Guolin
    NANOTECHNOLOGY, 2024, 35 (31)
  • [10] Intracellular pH-responsive and rituximabconjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells
    Zhou, Shoubing
    Wu, Dan
    Yin, Xiaodong
    Jin, Xiaoxiao
    Zhang, Xiu
    Zheng, Shiya
    Wang, Cailian
    Liu, Yanwen
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36 : 1 - 14